166 related articles for article (PubMed ID: 29033834)
1. TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors.
Wall TR; Henderson BJ; Voren G; Wageman CR; Deshpande P; Cohen BN; Grady SR; Marks MJ; Yohannes D; Kenny PJ; Bencherif M; Lester HA
Front Pharmacol; 2017; 8():641. PubMed ID: 29033834
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
[TBL] [Abstract][Full Text] [Related]
3. Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptors.
van Hout M; Klein J; Ahring PK; Brown DT; Thaneshwaran S; Dos Santos AB; Jensen AA; Kohlmeier KA; Christophersen P; Dyhring T
Biochem Pharmacol; 2020 Apr; 174():113788. PubMed ID: 31887290
[TBL] [Abstract][Full Text] [Related]
4. Enhanced synthesis and release of dopamine in transgenic mice with gain-of-function α6* nAChRs.
Wang Y; Lee JW; Oh G; Grady SR; McIntosh JM; Brunzell DH; Cannon JR; Drenan RM
J Neurochem; 2014 Apr; 129(2):315-27. PubMed ID: 24266758
[TBL] [Abstract][Full Text] [Related]
5. Nicotinic acetylcholine receptors containing α6 subunits contribute to alcohol reward-related behaviours.
Powers MS; Broderick HJ; Drenan RM; Chester JA
Genes Brain Behav; 2013 Jul; 12(5):543-53. PubMed ID: 23594044
[TBL] [Abstract][Full Text] [Related]
6. Deletion of lynx1 reduces the function of α6* nicotinic receptors.
Parker RL; O'Neill HC; Henley BM; Wageman CR; Drenan RM; Marks MJ; Miwa JM; Grady SR; Lester HA
PLoS One; 2017; 12(12):e0188715. PubMed ID: 29206881
[TBL] [Abstract][Full Text] [Related]
7. Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonists.
Capelli AM; Castelletti L; Chen YH; Van der Keyl H; Pucci L; Oliosi B; Salvagno C; Bertani B; Gotti C; Powell A; Mugnaini M
Br J Pharmacol; 2011 May; 163(2):313-29. PubMed ID: 21232042
[TBL] [Abstract][Full Text] [Related]
8. r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement.
Beckmann JS; Meyer AC; Pivavarchyk M; Horton DB; Zheng G; Smith AM; Wooters TE; McIntosh JM; Crooks PA; Bardo MT; Dwoskin LP
Neurochem Res; 2015 Oct; 40(10):2121-30. PubMed ID: 26227997
[TBL] [Abstract][Full Text] [Related]
9. The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
Rollema H; Hurst RS
Psychopharmacology (Berl); 2018 Sep; 235(9):2479-2505. PubMed ID: 29980822
[TBL] [Abstract][Full Text] [Related]
10. Long-term nicotine treatment differentially regulates striatal alpha6alpha4beta2* and alpha6(nonalpha4)beta2* nAChR expression and function.
Perez XA; Bordia T; McIntosh JM; Grady SR; Quik M
Mol Pharmacol; 2008 Sep; 74(3):844-53. PubMed ID: 18583454
[TBL] [Abstract][Full Text] [Related]
11. Heterologous expression and nonsense suppression provide insights into agonist behavior at α6β2 nicotinic acetylcholine receptors.
Post MR; Limapichat W; Lester HA; Dougherty DA
Neuropharmacology; 2015 Oct; 97():376-82. PubMed ID: 25908401
[TBL] [Abstract][Full Text] [Related]
12. Characterization of AN317, a novel selective agonist of α6β2-containing nicotinic acetylcholine receptors.
Sandager-Nielsen K; Ahring PK; Klein J; van Hout M; Thaneshwaran S; Dos Santos AB; Jacobsen TA; Amrutkar DV; Peters D; Jensen AA; Kohlmeier KA; Christophersen P; Dyhring T
Biochem Pharmacol; 2020 Apr; 174():113786. PubMed ID: 31887288
[TBL] [Abstract][Full Text] [Related]
13. Menthol Alone Upregulates Midbrain nAChRs, Alters nAChR Subtype Stoichiometry, Alters Dopamine Neuron Firing Frequency, and Prevents Nicotine Reward.
Henderson BJ; Wall TR; Henley BM; Kim CH; Nichols WA; Moaddel R; Xiao C; Lester HA
J Neurosci; 2016 Mar; 36(10):2957-74. PubMed ID: 26961950
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of mesolimbic alpha 3/alpha 6 beta 2 and alpha 4 beta 2 nicotinic acetylcholine receptor sites and function after long-term oral nicotine to monkeys.
McCallum SE; Parameswaran N; Bordia T; Fan H; McIntosh JM; Quik M
J Pharmacol Exp Ther; 2006 Jul; 318(1):381-8. PubMed ID: 16622038
[TBL] [Abstract][Full Text] [Related]
15. Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity.
Sumithran SP; Crooks PA; Xu R; Zhu J; Deaciuc AG; Wilkins LH; Dwoskin LP
AAPS J; 2005 Aug; 7(1):E201-17. PubMed ID: 16146341
[TBL] [Abstract][Full Text] [Related]
16. Characterization of nicotinic acetylcholine receptors that modulate nicotine-evoked [3H]norepinephrine release from mouse hippocampal synaptosomes.
Azam L; McIntosh JM
Mol Pharmacol; 2006 Sep; 70(3):967-76. PubMed ID: 16735605
[TBL] [Abstract][Full Text] [Related]
17. Probing for and Quantifying Agonist Hydrogen Bonds in α6β2 Nicotinic Acetylcholine Receptors.
Post MR; Lester HA; Dougherty DA
Biochemistry; 2017 Apr; 56(13):1836-1840. PubMed ID: 28287260
[TBL] [Abstract][Full Text] [Related]
18. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice.
Champtiaux N; Gotti C; Cordero-Erausquin M; David DJ; Przybylski C; Léna C; Clementi F; Moretti M; Rossi FM; Le Novère N; McIntosh JM; Gardier AM; Changeux JP
J Neurosci; 2003 Aug; 23(21):7820-9. PubMed ID: 12944511
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Nicotinic Acetylcholine Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(carbamoylpyridinyl)deschloroepibatidine Analogues.
Ondachi PW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
ACS Chem Neurosci; 2016 Jul; 7(7):1004-12. PubMed ID: 27166021
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity alpha4beta2 subunit combination.
Anderson DJ; Malysz J; Grønlien JH; El Kouhen R; Håkerud M; Wetterstrand C; Briggs CA; Gopalakrishnan M
Biochem Pharmacol; 2009 Oct; 78(7):844-51. PubMed ID: 19555668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
